DDrare: Database of Drug Development for Rare Diseases

83. アジソン病
［臨床試験数：20，薬物数：42（DrugBank：13），標的遺伝子数：6，標的パスウェイ数：17］

Searched query = "Addison disease", "Primary chronic adrenocortical insufficiency", "Autoimmune polyglandular syndrome", "Hypoparathyroidism-Addison-Monilia syndrome", "HAM syndrome", "Schmidt syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Acetate; Cortef; Cortef (hydrocortisone); Cortef 5 mg; Cosyntropin; Dehydroepiandrosterone; Depot tetracosactide; Device: 30-hour ambulatory sampling of intestinal fluid; Dexamethasone; Diagnostic Test: Baseline blood tests; Diagnostic Test: Cosyntropin stimulation test; Grapefruit; Grapefruit Juice; HYDROCORTISONE HYDROGEN SUCCINATE; HYDROCORTISONE ROUSSEL; HYDROCORTISONE SODIUM SUCCINATE; Hydrocortison 100 mg (Pfizer®) in 2 ml solvent; Hydrocortisone; Hydrocortisone 100mg/ml; Hydrocortisone Roussel; Hydrocortisone hydrogen succinate; Hydrocortisone sodium phosphate; Hydrocortisonum; Hydrogen; Hydrokortison APL kapsel 2,5 mg; Isocaloric Diet; Liquorice; MabThera; Mabthera Infusion; Mabthera infusion; Medrone; Methylprednisolone; Phosphate; Rituximab; Solu-Cortef; Solu-Cortef (hydrocortisone); Solu-Medrone; Solu-cortef; Solu-medrone; Synacthen Depot; Tetracosactide; Tetracosactide acetate

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004313 (ClinicalTrials.gov)	August 1995	18/10/1999	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency		Addison's Disease	Drug: dehydroepiandrosterone	National Center for Research Resources (NCRR)	University of California, Los Angeles	Completed	18 Years	N/A	Both	40	Phase 3	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00004313
(ClinicalTrials.gov)

August 1995

18/10/1999

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal Insufficiency

Addison's Disease

Drug: dehydroepiandrosterone

National Center for Research Resources (NCRR)

University of California, Los Angeles

Completed

18 Years

N/A

Both

Phase 3

NULL